Results 171 to 180 of about 20,865 (263)

A city-scale optimization framework for biomass-to-clean-energy transitions: The KAMPALA-TIMES model. [PDF]

iScience
Kimuli I, Kirabira JB, Mujjuni F.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Hemophagocytic lymphohistiocytosis poses a substantial socio-economic burden in China. [PDF]

Chin Med J (Engl)
Li M, Cao J, Liu H, He H, Wang J, Wang Z.   +5 more
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Harnessing oil revenues for sustainable development: evaluating Brazil's "royalties' law" and its impact on healthcare. [PDF]

Health Econ Rev
de A Rodrigues RE, de Farias Souza WPS, de Araújo JM.   +2 more
europepmc   +1 more source

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

British Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang, Ana Soldo, Olgica Velkovski Škopić, Sunčana Vlah Tomičević, Tin Šaban, Andrej Belančić, Ana Jelaković, Josipa Josipović, Mihaela Marinović Glavić, Ivan Pećin, Luka Prgomet, Tajana Željković Vrkić, Bojan Jelaković   +12 more
wiley   +1 more source

Why will increasing medical insurance reimbursement levels not lead to over-medicalization? Evidence from China's medical insurance payment reform. [PDF]

Cost Eff Resour Alloc
Yingtan M, Yaxuan Z, Qiuming H.
europepmc   +1 more source

Estimating the economic burden of lower respiratory infections in China from 2020 to 2040: a health-augmented macroeconomic modelling study. [PDF]

Lancet Reg Health West Pac
Lin Y, Sun H, Cao Z, Prettner K, Xu X, Zhou Y, Yin P, Bloom DE, Kuhn M, Bärnighausen TW, Cao B, Zhou M, Chen S.   +12 more
europepmc   +1 more source

String Figuring young children's perspectives of quality in English early childhood education and care

British Educational Research Journal, EarlyView.
Abstract Quality in early childhood education and care (ECEC) is a contested concept and has generally been conceptualised by inter‐related indicators such as staff qualifications, educational environment, policy or child‐to‐staff ratios. There has been a more limited emphasis on how young children might perceive and experience quality.
Nikki Fairchild, Éva Mikuska
wiley   +1 more source

What affects rural households' entrepreneurial performance: Formal or informal finance availability? [PDF]

PLoS One
Xiang Z, Yin Q, Xue X, Zhang W, Wang X.
europepmc   +1 more source